We are live on
!
Find out more
X
Xponance Portfolio holdings
AUM
$16.3B
1-Year Est. Return
44.61%
This Fund
S&P 500
This Quarter
Est. Return
+11.71%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.51B
AUM Growth
+$668M
(+9.8%)
Cap. Flow
+$14M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
34.2%
Holding
1,319
New
77
Increased
462
Reduced
700
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$45.1M |
| 2 |
Home Depot
HD
|
+$13.5M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$10.9M |
| 4 |
Salesforce
CRM
|
+$10.2M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$10.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$9.39M |
| 2 |
Coca-Cola
KO
|
+$9.33M |
| 3 |
United Parcel Service
UPS
|
+$8.35M |
| 4 |
IBM
IBM
|
+$7.74M |
| 5 |
Union Pacific
UNP
|
+$6.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.15% |
| 2 | Consumer Discretionary | 12.56% |
| 3 | Healthcare | 12.54% |
| 4 | Financials | 10.24% |
| 5 | Communication Services | 8.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
ADMA Biologics
ADMA
$2.12B
| $48.5K | ﹤0.01% |
13,156
+1,271
| +11% | +$4.71K |
|
|
NKLA
1227
DELISTED
Nikola Corporation Common Stock
NKLA
| $48K | ﹤0.01% |
1,159
+513
| +79% | +$14.1K |
|
|
PGRE
1228
DELISTED
Paramount Group
PGRE
| $48K | ﹤0.01% |
10,824
| – | – |
|
1229
Microvision
MVIS
$57.5M
| $47.2K | ﹤0.01% |
+687
| New | +$36.1K |
|
|
BDN
1230
Brandywine Realty Trust
BDN
$534M
| $46.9K | ﹤0.01% |
+10,082
| New | +$41.1K |
|
|
CTEV
1231
Claritev Corp
CTEV
$657M
| $46.8K | ﹤0.01% |
555
+17
| +3% | +$908 |
|
|
MTTR
1232
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $45.5K | ﹤0.01% |
14,453
+1,685
| +13% | +$4.67K |
|
|
TELL
1233
DELISTED
Tellurian Inc.
TELL
| $43.8K | ﹤0.01% |
31,085
+1,921
| +7% | +$2.58K |
|
1234
Globalstar
GSAT
$10.6B
| $43.7K | ﹤0.01% |
2,697
+93
| +4% | +$1.49K |
|
1235
Brookdale Senior Living
BKD
$2.89B
| $42.7K | ﹤0.01% |
10,130
-480
| -5% | -$1.85K |
|
1236
Ardelyx
ARDX
$986M
| $42.5K | ﹤0.01% |
+12,537
| New | +$51.4K |
|
1237
SmartRent
SMRT
$261M
| $41.7K | ﹤0.01% |
+10,889
| New | +$33.3K |
|
1238
Pitney Bowes
PBI
$2.37B
| $36.5K | ﹤0.01% |
+10,306
| New | +$35.7K |
|
1239
Planet Labs
PL
$7.54B
| $35.1K | ﹤0.01% |
10,916
| – | – |
|
|
EQRX
1240
DELISTED
EQRx, Inc. Common Stock
EQRX
| $35K | ﹤0.01% |
18,795
+7,301
| +64% | +$13.1K |
|
1241
Conduent
CNDT
$271M
| $34.3K | ﹤0.01% |
+10,089
| New | +$33K |
|
|
AGEN
1242
Agenus
AGEN
$352M
| $31.8K | ﹤0.01% |
993
+105
| +12% | +$3.36K |
|
|
SHCR
1243
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $31.3K | ﹤0.01% |
17,874
+1,373
| +8% | +$2.15K |
|
|
DHC
1244
Diversified Healthcare Trust
DHC
$1.9B
| $30.7K | ﹤0.01% |
13,634
| – | – |
|
1245
American Well
AMWL
$200M
| $30K | ﹤0.01% |
714
+58
| +9% | +$2.56K |
|
|
DM
1246
DELISTED
Desktop Metal, Inc.
DM
| $29K | ﹤0.01% |
1,636
+109
| +7% | +$2.19K |
|
1247
Clear Channel Outdoor Holdings
CCO
$1.22B
| $28.8K | ﹤0.01% |
21,031
| – | – |
|
|
ME
1248
DELISTED
23andMe Holding Co
ME
| $25.8K | ﹤0.01% |
736
| – | – |
|
|
IAUX
1249
i-80 Gold Corp
IAUX
$1.66B
| $25.6K | ﹤0.01% |
+11,380
| New | +$26.8K |
|
1250
Cerus
CERS
$548M
| $25.5K | ﹤0.01% |
+10,375
| New | +$24.7K |
|
Similar funds
PCM
LPC
CAM
MFG
PAM
BS
BBVA
NMO
Xponance's Q2 2023 Portfolio in Review
As of Q2 2023, Xponance held 1,319 positions worth $7.51B, up 9.8% from $6.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Xponance's Q2 2023 filing shows 77 new, 462 increased, 700 reduced and 61 closed positions. Its largest new stake was Coupang: 152,372 shares worth $2.65M. The largest sale was Procter & Gamble, an estimated $9.39M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Xponance's largest Q2 2023 buy was Coupang: 152,372 shares worth $2.65M.
- Xponance added most to Meta Platforms (Facebook) in Q2 2023, an estimated $45.1M increase.
- Xponance's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $9.39M.
- Xponance fully exited iShares Core MSCI International Developed Markets ETF in Q2 2023, selling an estimated $681K.
- Xponance's ten largest holdings make up 34% of its $7.51B portfolio in Q2 2023.
- Xponance opened 77 new positions and closed 61 in Q2 2023.
- Xponance's portfolio value rose 9.8% quarter-over-quarter to $7.51B.
Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.